Axsome Therapeutics is a New York-based pharmaceutical company dedicated to developing innovative treatments for central nervous system (CNS) conditions, including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia.
The company is committed to improving the lives of patients by turning their needs into breakthrough discoveries, with a pipeline of promising products such as AXS-05, AXS-07, AXS-12, and AXS-14.
Generated from the website